Skip to main content
. 2010 May 24;25(6):882–887. doi: 10.3346/jkms.2010.25.6.882

Fig. 1.

Fig. 1

Complete response rate (hatched bar) and breakthrough rate (black bar) during a 24 months-course of lamivudine therapy in HBeAg negative CHB patients. Complete response was defined as having both ALT normalization and HBV DNA undetectability (<0.5 pg/mL) as measured by the hybrid capture assay. Clinical breakthrough was defined as HBV DNA positive conversion with ALT re-elevation.